At the Michigan Pharmacy Provider Liaison Quarterly Meeting. Discussion focused on clarifications of several policy documents. The next pharmacy liaison meeting will be held on June 9.
Final Policies Issued
HASA 22-02: COVID-19 Response: Coverage of FDA Emergency Use Authorization (EUA) COVID-19 Monoclonal Antibody Injections by Pharmacy Providers
Published L-Letters
L 22-05: Clarification of Michigan Automated Prescription System (MAPS)
Record Retention
L 22-04: Additional Guidance and Clarification for the Coverage of COVID- 19 Prevention, Treatment, and Support Services.
Proposed Policy:
2156-Pharmacy: Signature Log and Proof of Delivery Requirements
2202-Pharmacy: COVID-19 Response: Coverage of U.S. Food & Drug Administration (FDA) Emergency Use Authorization (EUA) COVID-19 Monoclonal Antibody Injections by Pharmacy Providers
2155-Pharmacy: Update to Contraceptive Supply Limit
Web Announcements:
Summary of Michigan Single PDL (Preferred Drug List) Changes – effective 2/01/2022 https://michigan.magellanrx.com/provider/external/medicaid/mi/doc/en us/MIRx PDL changes.pdf
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.